Monoclonal evolution of angioimmunoblastic lymphadenopathy

Area of Science:

• Hematology
• Oncology
• Immunopathology

Background:

• Angioimmunoblastic lymphadenopathy (AIL) is an aggressive T-cell lymphoma.
• AIL is characterized by lymphadenopathy, hypergammaglobulinemia, and immune dysregulation.

Observation:

• A patient initially diagnosed with AIL showed progression to immunoblastic lymphoma upon rebiopsy.
• Initial presentation revealed polyclonal hypergammaglobulinemia and polyclonal immunoblasts.
• Subsequent disease course showed development of monoclonal IgM kappa gammaglobulinemia and monoclonal kappa light chain immunoblasts.

Findings:

• The patient's disease evolved from a polyclonal to a monoclonal immunoblast population.
• This monoclonal evolution correlated with lymphomatous transformation and clinical deterioration.
• Immunoperoxidase staining confirmed the shift in immunoblast clonality.

Implications:

• These findings highlight the heterogeneous nature of AIL.
• Demonstrates the malignant potential and capacity for transformation in AIL.
• Suggests a need for careful monitoring of patients with AIL for evolving disease characteristics.